The study of Pharmacodynamics focuses on how medications affect the body. The drug's interaction with tissue receptors found within cell membranes or intracellular fluid is the most frequent method. The amount of the activating medication (the "agonist") affects the degree of receptor activation and the ensuing biological reaction. The dose-response curve, which charts the medication dose (or concentration) against its effect, provides an explanation for this relationship. Patient characteristics (such as age and illness) and the availability of additional medications that compete with it for binding at the same receptor (such as receptor "antagonists") might have an impact on this crucial pharmacodynamic interaction. Some medications that operate on the same receptor (or tissue) differ in their ability to produce large biological reactions (i.e., their "efficacy") and the dosage needed to produce such responses (i.e., their "potency"). Drug receptors can be categorised according to how selectively they react to various medicines. Drugs can occasionally cause a diminished reaction when receptors or bodily systems are exposed to them repeatedly
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia